BetaKine data

CTRX (Santa Clara, Calif.) released its final analysis of a 36-patient closed-label Phase II study of BetaKine to treat venous stasis ulcers. Patients in the treatment arm received 2.5 µg/cm 2 of BetaKine delivered in

Read the full 359 word article

How to gain access

Continue reading with a
two-week free trial.